News

For much of the past five years, shares of Lululemon Athletica Inc (NASDAQ: LULU) traded more like a tech stock than a fashion company and experienced all the highs and lows that come with that

Shares of Shopify Inc. (NYSE: SHOP) are up more than 100% year-to-date, and some may wonder if now is the time to ring the register. Based on the trends and some recent news, the answer to that

Having endured a terrible 2021 that continued for much of 2022, it's starting to look like a solid low has been put in by online retail stocks, with a recovery rally imminent. Looking at the

Telecom stocks have long been popular value plays for investors seeking a superior dividend yield with a modestly conservative investment approach. Household names like Comcast (NASDAQ: CMCSA)

Telecom stocks have long been popular value plays for investors seeking a superior dividend yield with a modestly conservative investment approach. Household names like Comcast (NASDAQ: CMCSA)

Once again, Marketbeat.com’s list of Most Downgraded Stocks has some interesting names. While some are worthy of bearish sentiment, others are on the list because the analysts have reset their

Outdoor recreation got a big boost during the pandemic as social distancing and lockdowns caused people to seek out other forms of leisure and entertainment that didn't involve human interactions.

Cloudflare Inc. (NYSE: NET) shares are up only fractionally since the company's second-quarter report on August 3, after it's been the subject of conflicting analyst calls.

Revenue grew  32%

Cloudflare Inc. (NYSE: NET) shares are up only fractionally since the company's second-quarter report on August 3, after it's been the subject of conflicting analyst calls.

Revenue grew  32%

When GoodRx Holdings, Inc. (NASDAQ:GDRX) burst onto the scene in the middle of the pandemic, it brought promises of saving Americans money on their drug prescriptions. While consumers have indeed

When GoodRx Holdings, Inc. (NASDAQ:GDRX) burst onto the scene in the middle of the pandemic, it brought promises of saving Americans money on their drug prescriptions. While consumers have indeed

BioMarin (NASDAQ: BMRN) shares have been under pressure due to delays in approving its hemophilia A drug Roctavian. That is over. The drug, which targets hemophilia A in a 1-time treatment, was

BioMarin (NASDAQ: BMRN) shares have been under pressure due to delays in approving its hemophilia A drug Roctavian. That is over. The drug, which targets hemophilia A in a 1-time treatment, was

Most investors are pretty up-to-speed on how the AI boom contributed to supersized gains in the tech sector in the second quarter. Heavily-weighted stocks such as Apple Inc. (NASDAQ: AAPL)